Correlation Between Merck and ALPS
Can any of the company-specific risk be diversified away by investing in both Merck and ALPS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and ALPS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and ALPS, you can compare the effects of market volatilities on Merck and ALPS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of ALPS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and ALPS.
Diversification Opportunities for Merck and ALPS
Pay attention - limited upside
The 3 months correlation between Merck and ALPS is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and ALPS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALPS and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with ALPS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALPS has no effect on the direction of Merck i.e., Merck and ALPS go up and down completely randomly.
Pair Corralation between Merck and ALPS
If you would invest 9,836 in Merck Company on September 15, 2024 and sell it today you would earn a total of 364.00 from holding Merck Company or generate 3.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 4.76% |
Values | Daily Returns |
Merck Company vs. ALPS
Performance |
Timeline |
Merck Company |
ALPS |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Merck and ALPS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and ALPS
The main advantage of trading using opposite Merck and ALPS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, ALPS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALPS will offset losses from the drop in ALPS's long position.Merck vs. Emergent Biosolutions | Merck vs. Bausch Health Companies | Merck vs. Neurocrine Biosciences | Merck vs. Teva Pharma Industries |
ALPS vs. Humankind Benefit | ALPS vs. Gabelli ETFs Trust | ALPS vs. Gotham Enhanced 500 | ALPS vs. Goldman Sachs Future |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
CEOs Directory Screen CEOs from public companies around the world |